Researchers discovered a hidden molecular “switch” that herpes viruses rely on to invade cells. By combining AI, simulations, ...
Q: I'm 62 and have had genital herpes for years. Although it's pretty well under control, my doctor says I have to worry about how it affects my brain! Is that true? -- Frankie Y., Akron, Ohio ...
The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...
A mid-stage study for ABI-5366 will begin mid next year, while Assembly continues to assess the Phase II potential of ...
TipRanks on MSN
Assembly Biosciences reports positive phase 1b results
On December 8, 2025, Assembly Biosciences announced positive interim results from Phase 1b clinical studies of its investigational herpes simplex virus (HSV) helicase-primase inhi ...
Additionally, Assembly Bio’s monthly oral dose of ABI-5366 achieved a 76% reduction in HSV-2 shedding rate, 81% reduction in ...
Herpes simplex virus (HSV) is a common infection with two main types, HSV-1 and HSV-2, typically affecting the mouth or ...
Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells.
Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack ...
Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells. A ...
Mass General Brigham researchers engineer a virus that destroys brain tumor cells while avoiding healthy brain tissue ...
Scientists create a retargeted herpes virus that safely attacks glioblastoma and boosts immune response, showing promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results